Aifen Wang

500 total citations
17 papers, 337 citations indexed

About

Aifen Wang is a scholar working on Oncology, Cancer Research and Computer Networks and Communications. According to data from OpenAlex, Aifen Wang has authored 17 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Cancer Research and 3 papers in Computer Networks and Communications. Recurrent topics in Aifen Wang's work include Advanced Wireless Communication Techniques (3 papers), Wireless Communication Networks Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Aifen Wang is often cited by papers focused on Advanced Wireless Communication Techniques (3 papers), Wireless Communication Networks Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Aifen Wang collaborates with scholars based in China and United States. Aifen Wang's co-authors include Robert Clarke, Ayesha N. Shajahan‐Haq, Yuelin J. Zhu, Anatasha Crawford, Mingyue Wang, Bianca Gomez, Alan Zwart, Rebecca B. Riggins, Richard D. Minshall and Sen Lu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The FASEB Journal.

In The Last Decade

Aifen Wang

15 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aifen Wang China 7 198 139 76 75 66 17 337
Shengnan Ruan China 10 219 1.1× 77 0.6× 88 1.2× 139 1.9× 78 1.2× 22 386
Claudia Tredup Germany 10 219 1.1× 122 0.9× 69 0.9× 80 1.1× 35 0.5× 15 415
Zheyong Liang China 9 274 1.4× 107 0.8× 99 1.3× 112 1.5× 34 0.5× 17 411
Bowen Xing China 11 211 1.1× 141 1.0× 151 2.0× 47 0.6× 60 0.9× 22 458
Seo Hee Nam South Korea 14 251 1.3× 101 0.7× 124 1.6× 79 1.1× 68 1.0× 24 446
Tomoko Ueda Japan 9 167 0.8× 76 0.5× 57 0.8× 34 0.5× 21 0.3× 23 310
Rachel S. Salamon United States 9 317 1.6× 69 0.5× 69 0.9× 42 0.6× 38 0.6× 10 436
Caifeng Yue China 9 305 1.5× 84 0.6× 113 1.5× 150 2.0× 66 1.0× 20 481
Zhehui Zhu China 8 165 0.8× 51 0.4× 86 1.1× 54 0.7× 54 0.8× 18 332
James Yao United States 8 207 1.0× 117 0.8× 186 2.4× 50 0.7× 159 2.4× 9 433

Countries citing papers authored by Aifen Wang

Since Specialization
Citations

This map shows the geographic impact of Aifen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aifen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aifen Wang more than expected).

Fields of papers citing papers by Aifen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aifen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aifen Wang. The network helps show where Aifen Wang may publish in the future.

Co-authorship network of co-authors of Aifen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Aifen Wang. A scholar is included among the top collaborators of Aifen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aifen Wang. Aifen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Yayun, et al.. (2025). Cervical length of preoperative cervical cerclage prognostic impacted the effect of cervical insufficiency. BMC Pregnancy and Childbirth. 25(1). 12–12.
2.
Xu, Jiaqi, et al.. (2023). A nomogram for predicting prognosis of patients with cervical cerclage. Heliyon. 9(11). e21147–e21147. 20 indexed citations
3.
Wang, Aifen, et al.. (2023). Survival prognosis model for elderly women with epithelial ovarian cancer based on the SEER database. Frontiers in Oncology. 13. 1257615–1257615. 6 indexed citations
4.
Wang, Aifen, et al.. (2022). The effect of advances in epithelial ovarian cancer treatment on population mortality.. Journal of Clinical Oncology. 40(16_suppl). 5540–5540. 3 indexed citations
5.
Wang, Yujin, Qingwen Wang, Donghu Yu, et al.. (2021). Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation. Journal of Cancer Research and Clinical Oncology. 147(11). 3245–3254. 2 indexed citations
6.
Huang, Jingyu, Aifen Wang, Ganjun Kang, Dejia Li, & Weidong Hu. (2020). Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery. Journal of Thoracic and Cardiovascular Surgery. 160(2). e91–e93. 6 indexed citations
7.
Song, Congkuan, Hongyun Gong, Peter Liu, et al.. (2020). An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study. Journal of Cancer Research and Clinical Oncology. 147(4). 1247–1257. 8 indexed citations
8.
Lu, Sen, et al.. (2020). Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer. BMC Cancer. 20(1). 241–241. 30 indexed citations
9.
Wang, Aifen, et al.. (2020). Clinicopathologic analysis of MMR gene mutations and uterine adenocarcinomas: An updated population-based study.. Journal of Clinical Oncology. 38(15_suppl). e18100–e18100. 1 indexed citations
10.
Zhang, Yaqun, Lingfan Xu, Yan Chang, et al.. (2019). Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC. Prostate Cancer and Prostatic Diseases. 23(1). 160–171. 34 indexed citations
11.
Wang, Aifen, Jenna McCracken, Yanjing Li, & Lingfan Xu. (2018). The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma. Health Science Reports. 1(7). e43–e43. 7 indexed citations
12.
Song, Binbin, et al.. (2018). Application of Bone Turnover Markers PICP and β-CTx in the Diagnosis and Treatment of Breast Cancer with Bone Metastases. Clinical Laboratory. 64(01+02/2018). 11–16. 5 indexed citations
13.
Wang, Aifen, et al.. (2012). Comparison of Several SNR Estimators for QPSK Modulations. 77–80.
14.
Wang, Aifen, et al.. (2012). NDA moment-based SNR estimation for envelope-based QAM. 1341–1344. 4 indexed citations
15.
Wang, Aifen, et al.. (2012). NDA SNR estimation based on Empirical Characteristic Function and high-moment. 1464–1467. 1 indexed citations
16.
Gomez, Bianca, Rebecca B. Riggins, Ayesha N. Shajahan‐Haq, et al.. (2007). Human X‐Box binding protein‐1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. The FASEB Journal. 21(14). 4013–4027. 151 indexed citations
17.
Shajahan‐Haq, Ayesha N., Aifen Wang, Markus Decker, et al.. (2006). Caveolin-1 Tyrosine Phosphorylation Enhances Paclitaxel-mediated Cytotoxicity. Journal of Biological Chemistry. 282(8). 5934–5943. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026